Market Cap 6.25B
Revenue (ttm) 383.48M
Net Income (ttm) -146.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -38.17%
Debt to Equity Ratio 0.00
Volume 477,100
Avg Vol 1,193,064
Day's Range N/A - N/A
Shares Out 57.44M
Stochastic %K 56%
Beta 0.69
Analysts Strong Sell
Price Target $121.93

Company Profile

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The company offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. It also provides iStent infinite indicated for use in the treatment of patient...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 367 9600
Fax: 949 367 9984
Address:
One Glaukos Way, Aliso Viejo, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:14 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $109.93, significantly above its 30-day moving average (MA30) of $96.94 and 50-day moving average (MA50) of $90.94, indicating strong bullish momentum. The RSI is at 83.1, signaling overbought conditions, which may lead to a pullback or consolidation. Directional Bias: The strong RSI and proximity to the 60-day high of $112.00 suggest a bullish bias, but caution is warranted due to overbought signals. Suggested Trade Plan: - Entry: $109.93 - Stop Loss: $106.21 (2% below entry, based on ATR) - Take Profit Targets: 1. $112.00 (2% gain) 2. $115.00 (4.1% gain) 3. $128.00 (16.5% gain) This plan targets a minimum of 17% ROI on the third take profit. Monitor price action closely, as the high RSI may indicate a potential reversal. Adjust stop loss to lock in profits as targets are approached. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:02 PM
Citigroup updates rating for Glaukos ( $GKOS ) to Buy, target set at 113 → 125.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:17 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $106.87, showing strong momentum as indicated by an RSI of 80.06, suggesting it is overbought. However, the price is near the 60D high of $112.00, indicating potential resistance ahead. Directional Bias: The bullish trend is supported by the MA30 at $94.82 and MA50 at $89.86, both below the current price. The significant gap between the price and MAs suggests continued upward momentum, but caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $106.87 - Stop Loss: $102.00 (approx. 4.0% below entry) - Take Profit Targets: 1. $110.00 (approx. 2.0% gain) 2. $112.00 (approx. 4.0% gain) 3. $125.00 (approx. 17.0% gain) This plan provides a clear strategy with a favorable risk-reward ratio, targeting significant upside while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 6:58 PM
Needham has adjusted their stance on Glaukos ( $GKOS ), setting the rating to Buy with a target price of 117 → 125.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:06 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $107.65, showing strong bullish momentum with an RSI of 84.63, indicating overbought conditions. The price is significantly above the 30-day MA of $93.75 and the 50-day MA of $89.34, suggesting a strong upward trend. The recent 60-day high of $112.00 presents a key resistance level. Directional Bias: The high RSI indicates potential for a pullback, but the strong price action suggests that momentum may continue in the short term. The range between the 60-day high ($112.00) and low ($73.16) supports a bullish outlook. Suggested Trade Plan: - Entry: $107.65 - Stop Loss: $103.60 (below recent support) - Take Profit Targets: 1. $110.00 (2.18% gain) 2. $112.00 (4.32% gain) 3. $126.00 (17.00% gain) This plan aims for a minimum of 17% ROI on the third target while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TaoistTrader
TaoistTrader Dec. 8 at 3:24 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:05 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS closed at $108.85, showing strong momentum with an RSI of 78.4, indicating overbought conditions. The stock is trading significantly above its MA30 (91.54) and MA50 (88.24), suggesting bullish sentiment but potential for a pullback. Directional Bias: The strong RSI and proximity to the 60D high of $110.02 support a bullish outlook. However, the overbought RSI signals caution, as a correction could occur. Trade Plan: - Suggested Entry: $108.85 - Stop Loss: $104.64 (approx. 4% below entry) - Take Profit Targets: 1. $112.00 (3.9% gain) 2. $115.00 (5.8% gain) 3. $127.50 (17.2% gain) With the potential for a significant ROI on the third target, this plan allows for strategic profit-taking while managing risk. Monitor the stock closely for volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:40 PM
Actionable Trade Alert for $GKOS: Market Context: $GKOS closed at $108.85, showing strong momentum with an RSI of 78.4, indicating overbought conditions. The stock is trading significantly above its MA30 (91.54) and MA50 (88.24), suggesting bullish sentiment but potential for a pullback. Directional Bias: The strong RSI and proximity to the 60D high of $110.02 support a bullish outlook. However, the overbought RSI signals caution, as a correction could occur. Trade Plan: - Suggested Entry: $108.85 - Stop Loss: $104.64 (approx. 4% below entry) - Take Profit Targets: 1. $112.00 (3.9% gain) 2. $115.00 (5.8% gain) 3. $127.50 (17.2% gain) With the potential for a significant ROI on the third target, this plan allows for strategic profit-taking while managing risk. Monitor the stock closely for volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 10:39 PM
$GKOS Current Stock Price: $108.51 Contracts to trade: $110 GKOS Dec 19 2025 Call Entry: $3.20 Exit: $4.33 ROI: 35% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Nov. 28 at 6:10 PM
$GKOS down 29.7% so far this year — poised for a rebound? 📈 🔹 iDose TR launch drives $40M in Q3 sales 🔹 Expanding pipeline with glaucoma, corneal health & retinal disease candidates 🔹 Navigating reimbursement hurdles, but growth strategy in place Opportunity assessment here 👉 https://www.zacks.com/stock/news/2797380/heres-why-you-should-retain-glaukos-stock-in-your-portfolio?cid=sm-stocktwits-2-2797380-body-22787&ADID=SYND_STOCKTWITS_TWEET_2_2797380_BODY_22787
0 · Reply
Latest News on GKOS
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday

Oct 30, 2025, 6:54 PM EDT - 6 weeks ago

Why Glaukos Stock Zoomed Almost 14% Higher on Thursday


Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 12:06 AM EDT - 6 weeks ago

Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript


Glaukos Announces Third Quarter 2025 Financial Results

Oct 29, 2025, 4:05 PM EDT - 6 weeks ago

Glaukos Announces Third Quarter 2025 Financial Results


US FDA approves Glaukos' new eye therapy

Oct 20, 2025, 7:10 AM EDT - 7 weeks ago

US FDA approves Glaukos' new eye therapy


Glaukos Announces FDA Approval of Epioxa™

Oct 20, 2025, 7:00 AM EDT - 7 weeks ago

Glaukos Announces FDA Approval of Epioxa™


Glaukos (GKOS) Q2 Revenue Jumps 30%

Aug 1, 2025, 1:54 AM EDT - 4 months ago

Glaukos (GKOS) Q2 Revenue Jumps 30%


Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 5:15 AM EDT - 4 months ago

Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript


Glaukos Announces Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 4 months ago

Glaukos Announces Second Quarter 2025 Financial Results


Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 10:05 PM EDT - 8 months ago

Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript


Glaukos Announces First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 8 months ago

Glaukos Announces First Quarter 2025 Financial Results


Glaukos Announces the Release of its 2024 Sustainability Report

Apr 16, 2025, 7:00 AM EDT - 8 months ago

Glaukos Announces the Release of its 2024 Sustainability Report


Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™

Feb 24, 2025, 7:00 AM EST - 10 months ago

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™


Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript

Feb 21, 2025, 4:29 AM EST - 10 months ago

Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript


Glaukos Corporation (GKOS) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:03 PM EST - 1 year ago

Glaukos Corporation (GKOS) Q3 2024 Earnings Call Transcript


Glaukos Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

Glaukos Announces Third Quarter 2024 Financial Results


Glaukos Corporation (GKOS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 8:57 PM EDT - 1 year ago

Glaukos Corporation (GKOS) Q2 2024 Earnings Call Transcript


Glaukos Announces Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Glaukos Announces Second Quarter 2024 Financial Results


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:14 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $109.93, significantly above its 30-day moving average (MA30) of $96.94 and 50-day moving average (MA50) of $90.94, indicating strong bullish momentum. The RSI is at 83.1, signaling overbought conditions, which may lead to a pullback or consolidation. Directional Bias: The strong RSI and proximity to the 60-day high of $112.00 suggest a bullish bias, but caution is warranted due to overbought signals. Suggested Trade Plan: - Entry: $109.93 - Stop Loss: $106.21 (2% below entry, based on ATR) - Take Profit Targets: 1. $112.00 (2% gain) 2. $115.00 (4.1% gain) 3. $128.00 (16.5% gain) This plan targets a minimum of 17% ROI on the third take profit. Monitor price action closely, as the high RSI may indicate a potential reversal. Adjust stop loss to lock in profits as targets are approached. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:02 PM
Citigroup updates rating for Glaukos ( $GKOS ) to Buy, target set at 113 → 125.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:17 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $106.87, showing strong momentum as indicated by an RSI of 80.06, suggesting it is overbought. However, the price is near the 60D high of $112.00, indicating potential resistance ahead. Directional Bias: The bullish trend is supported by the MA30 at $94.82 and MA50 at $89.86, both below the current price. The significant gap between the price and MAs suggests continued upward momentum, but caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $106.87 - Stop Loss: $102.00 (approx. 4.0% below entry) - Take Profit Targets: 1. $110.00 (approx. 2.0% gain) 2. $112.00 (approx. 4.0% gain) 3. $125.00 (approx. 17.0% gain) This plan provides a clear strategy with a favorable risk-reward ratio, targeting significant upside while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 6:58 PM
Needham has adjusted their stance on Glaukos ( $GKOS ), setting the rating to Buy with a target price of 117 → 125.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:06 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS is currently trading at $107.65, showing strong bullish momentum with an RSI of 84.63, indicating overbought conditions. The price is significantly above the 30-day MA of $93.75 and the 50-day MA of $89.34, suggesting a strong upward trend. The recent 60-day high of $112.00 presents a key resistance level. Directional Bias: The high RSI indicates potential for a pullback, but the strong price action suggests that momentum may continue in the short term. The range between the 60-day high ($112.00) and low ($73.16) supports a bullish outlook. Suggested Trade Plan: - Entry: $107.65 - Stop Loss: $103.60 (below recent support) - Take Profit Targets: 1. $110.00 (2.18% gain) 2. $112.00 (4.32% gain) 3. $126.00 (17.00% gain) This plan aims for a minimum of 17% ROI on the third target while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TaoistTrader
TaoistTrader Dec. 8 at 3:24 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:05 AM
Actionable Trade Alert for $GKOS: Market Context: $GKOS closed at $108.85, showing strong momentum with an RSI of 78.4, indicating overbought conditions. The stock is trading significantly above its MA30 (91.54) and MA50 (88.24), suggesting bullish sentiment but potential for a pullback. Directional Bias: The strong RSI and proximity to the 60D high of $110.02 support a bullish outlook. However, the overbought RSI signals caution, as a correction could occur. Trade Plan: - Suggested Entry: $108.85 - Stop Loss: $104.64 (approx. 4% below entry) - Take Profit Targets: 1. $112.00 (3.9% gain) 2. $115.00 (5.8% gain) 3. $127.50 (17.2% gain) With the potential for a significant ROI on the third target, this plan allows for strategic profit-taking while managing risk. Monitor the stock closely for volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:40 PM
Actionable Trade Alert for $GKOS: Market Context: $GKOS closed at $108.85, showing strong momentum with an RSI of 78.4, indicating overbought conditions. The stock is trading significantly above its MA30 (91.54) and MA50 (88.24), suggesting bullish sentiment but potential for a pullback. Directional Bias: The strong RSI and proximity to the 60D high of $110.02 support a bullish outlook. However, the overbought RSI signals caution, as a correction could occur. Trade Plan: - Suggested Entry: $108.85 - Stop Loss: $104.64 (approx. 4% below entry) - Take Profit Targets: 1. $112.00 (3.9% gain) 2. $115.00 (5.8% gain) 3. $127.50 (17.2% gain) With the potential for a significant ROI on the third target, this plan allows for strategic profit-taking while managing risk. Monitor the stock closely for volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 10:39 PM
$GKOS Current Stock Price: $108.51 Contracts to trade: $110 GKOS Dec 19 2025 Call Entry: $3.20 Exit: $4.33 ROI: 35% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Nov. 28 at 6:10 PM
$GKOS down 29.7% so far this year — poised for a rebound? 📈 🔹 iDose TR launch drives $40M in Q3 sales 🔹 Expanding pipeline with glaucoma, corneal health & retinal disease candidates 🔹 Navigating reimbursement hurdles, but growth strategy in place Opportunity assessment here 👉 https://www.zacks.com/stock/news/2797380/heres-why-you-should-retain-glaukos-stock-in-your-portfolio?cid=sm-stocktwits-2-2797380-body-22787&ADID=SYND_STOCKTWITS_TWEET_2_2797380_BODY_22787
0 · Reply
ZacksResearch
ZacksResearch Nov. 28 at 5:10 PM
Why $GKOS still deserves a spot in your portfolio 👀 The strong launch of iDose TR and a growing pipeline are clear momentum drivers, even as reimbursement hurdles remain part of the road ahead. Solid mix of upside and realism here. Full rundown here 👉 https://www.zacks.com/stock/news/2797380/heres-why-you-should-retain-glaukos-stock-in-your-portfolio?cid=sm-stocktwits-2-2797380-teaser-22785&ADID=SYND_STOCKTWITS_TWEET_2_2797380_TEASER_22785
0 · Reply
Estimize
Estimize Nov. 24 at 12:01 PM
Wall St is expecting -0.21 EPS for $GKOS Q4 [Reporting 02/19 AMC] http://www.estimize.com/intro/gkos?chart=historical&metric_name=eps&utm_c
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:44 PM
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Nov. 7 at 10:21 PM
$GKOS $CYBR $CAMT $VEEV Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off Brown Capital Management sold 376,359 shares of Glaukos for $34.6M in Q3. The sale represented about 1.4% of the fund's 13F assets. It retains 762,760 shares valued at $62.2M.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 11:48 PM
$GKOS Share Price: $81.75 Contract Selected: Apr 17, 2026 $80 Calls Buy Zone: $10.71 – $13.23 Target Zone: $17.21 – $21.04 Potential Upside: 52% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 6 at 5:38 PM
$GKOS Brown Capital’s $34.6M sale didn’t shake confidence—Glaukos’ glaucoma implants, 22% revenue growth, and $475M sales forecast fuel optimism. https://biotechhealthx.com/biotech-news/why-glaukos-gkos-could-surge-30-in-2025/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:48 PM
0 · Reply
TipRanks
TipRanks Nov. 4 at 11:11 AM
Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner https://www.tipranks.com/news/article/beaten-down-by-35-plus-analysts-say-these-2-oversold-stocks-are-poised-to-turn-the-corner $XNCR $GKOS
0 · Reply
ninergizer
ninergizer Oct. 30 at 9:19 PM
$INVA This is next, we hit $CRNX and $GKOS 25 % plus. Do your DD. PDUFA Date: Dec 15, 2025 Zoliflodacin — Oral antibiotic for gonorrhea FDA Likelihood: Very high (Priority Review, strong Phase 3, urgent CDC priority). Market Impact: Medium–large public health value, smaller direct commercial revenue. U.S. gonorrhea cases ~700k/year (CDC). New oral option = government/NGO contracts, global demand, less private pricing power. Potential: Blockbuster public health win, but sales may be constrained by stewardship and generic pricing.
0 · Reply
PrinceRobert
PrinceRobert Oct. 30 at 7:56 PM
$GKOS close my eyes! 👀
0 · Reply
PrinceRobert
PrinceRobert Oct. 30 at 6:14 PM
$GKOS Is time to pull back yet?
0 · Reply
Toptradersam
Toptradersam Oct. 30 at 6:00 PM
$CMBM $MTSR $GKOS $QCLS LFG!!! https://www.youtube.com/watch?v=Fy13hc2ICuo
0 · Reply